# Ulf Andréasson

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/ulf-andreasson/

## Facts

| Field | Value |
| --- | --- |
| Citations | 24,934 |
| Field | Alzheimer's disease research and treatments |
| h-index | 74 |
| i10-index | 186 |
| Last Known Institution | Sahlgrenska University Hospital |
| OpenAlex ID | https://openalex.org/A5057473716 |
| ORCID iD | https://orcid.org/0000-0001-8622-052X |
| Works | 303 |

## Researcher papers

- [Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology](https://scholariq.org/papers/diagnostic-value-of-cerebrospinal-fluid-neurofilament-light-protein-in-neurology/)
- [A Practical Guide to Immunoassay Method Validation](https://scholariq.org/papers/a-practical-guide-to-immunoassay-method-validation/)
- [The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers](https://scholariq.org/papers/the-alzheimer-s-association-external-quality-control-program-for-cerebrospinal/)
- [Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease](https://scholariq.org/papers/detailed-comparison-of-amyloid-pet-and-csf-biomarkers-for-identifying-early/)
- [CSF biomarker variability in the Alzheimer's Association quality control program](https://scholariq.org/papers/csf-biomarker-variability-in-the-alzheimer-s-association-quality-control-program/)
- [Safety and Tolerability of the γ-Secretase Inhibitor Avagacestat in a Phase 2 Study of Mild to Moderate Alzheimer Disease](https://scholariq.org/papers/safety-and-tolerability-of-the-secretase-inhibitor-avagacestat-in-a-phase-2/)
- [Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry](https://scholariq.org/papers/cerebrospinal-fluid-and-blood-biomarkers-for-neurodegenerative-dementias-an/)

## Researcher topics

- [Alzheimer's disease research and treatments](https://scholariq.org/topics/alzheimer-s-disease-research-and-treatments/)
- [Dementia and Cognitive Impairment Research](https://scholariq.org/topics/dementia-and-cognitive-impairment-research/)
- [Amyotrophic Lateral Sclerosis Research](https://scholariq.org/topics/amyotrophic-lateral-sclerosis-research/)
- [S100 Proteins and Annexins](https://scholariq.org/topics/s100-proteins-and-annexins/)
- [Amyloidosis: Diagnosis, Treatment, Outcomes](https://scholariq.org/topics/amyloidosis-diagnosis-treatment-outcomes/)

## Researcher university

- [Sahlgrenska University Hospital](https://scholariq.org/institutions/sahlgrenska-university-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.